Diet

India Dairy Industry Report 2024: Market Size, Growth, Prices, Segments, Cooperatives, Private Dairies, Procurement and Distribution 2023-2032 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 7, 2024

The "Dairy Industry in India 2024 Edition: Market Size, Growth, Prices, Segments, Cooperatives, Private Dairies, Procurement and Distribution" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dairy Industry in India 2024 Edition: Market Size, Growth, Prices, Segments, Cooperatives, Private Dairies, Procurement and Distribution" report has been added to ResearchAndMarkets.com's offering.
  • With the continual expansion of the population, the demand for dairy products is surging, providing a substantial consumer base for the industry.
  • This combination of demographic expansion and enhanced purchasing power has compelled dairy producers to scale up operations and innovate, ensuring steady market growth.
  • The dairy sector in the state thrives due to government initiatives, a strong network of milk cooperatives, and effective procurement and distribution systems.

United States Energy Drink Market Insights Report 2023-2027: From Diet vs. Regular to High-End and Organic Offerings - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 27, 2024

This research report looks at the energy category and its sub-sectors and nuances such as diet vs. regular, healthy energy, organic, high-end energy and shots.

Key Points: 
  • This research report looks at the energy category and its sub-sectors and nuances such as diet vs. regular, healthy energy, organic, high-end energy and shots.
  • What amount of energy drinks does the typical U.S. consumer drink in a year, and how has that changed?
  • How can I contact the leading energy drink and energy shot companies and succinctly ascertain what products they market in this segment?
  • Perspective on the energy shot market and healthy energy segment and players, and how they affect the mainstream energy drink market.

PK MED Announces FDA Clearance to Initiate Its Clinical Program for PKM-01, for Local Treatment of Gout Flares, Directly by a Phase 2 Trial

Retrieved on: 
Monday, February 26, 2024

During a Type B pre-IND meeting1, the Food and Drug Administration gave its clearance to directly initiate the clinical program for PKM-01 with a phase 2 trial for gout patients, without undertaking phase 1 studies.

Key Points: 
  • During a Type B pre-IND meeting1, the Food and Drug Administration gave its clearance to directly initiate the clinical program for PKM-01 with a phase 2 trial for gout patients, without undertaking phase 1 studies.
  • PKM-01 is a local intra-articular injection treatment for gout flares, developed by PK MED, aiming to provide a fast an effective pain relief and powerful and safe anti-inflammatory effect.
  • Thanks to its low-risk toxicity profile, PKM-01's clinical program will start directly in phase 2, which should considerably speed up time-to-market.
  • PK MED is now entering the fund-raising phase to finance PKM-01 phase 2 clinical trials.

GlobalData report highlights staggering $425.5 billion economic costs of obesity and overweight to U.S. Businesses and Employees in 2023

Retrieved on: 
Thursday, February 22, 2024

Obesity and overweight are estimated to have caused a staggering $425.5 billion in economic costs to U.S. businesses and employees in 2023, according to a report released by GlobalData Plc , a leading data and analytics company.

Key Points: 
  • Obesity and overweight are estimated to have caused a staggering $425.5 billion in economic costs to U.S. businesses and employees in 2023, according to a report released by GlobalData Plc , a leading data and analytics company.
  • Of the 158 million civilian employees on nonfarm payrolls, 30% (46.9M) are classified as having obesity and 34% (53.8M) have overweight.
  • Costs amounted to $347.5 billion attributed to obesity and $78 billion attributed to overweight.
  • Costs include $146.5 billion in higher medical costs for employees and their dependents, $82.3 billion in higher absenteeism (missed workdays), $160.3 billion in higher presenteeism (reduced productivity due to illness), $31.1 billion in higher disability costs, and $5.2 billion in higher Workers’ Compensation Program costs.

Best Meal Kits (2024): Best Purple Carrot Plant-Based Meal Delivery Reviewed by Compare Before Buying

Retrieved on: 
Wednesday, February 21, 2024

Compare Before Buying, a leading authority in consumer reviews, is excited to unveil its latest review focusing on Purple Carrot , acclaimed for offering the best plant-based meal kits in 2024.

Key Points: 
  • Compare Before Buying, a leading authority in consumer reviews, is excited to unveil its latest review focusing on Purple Carrot , acclaimed for offering the best plant-based meal kits in 2024.
  • Upon signing up for Purple Carrot's meal kit delivery service, customers are presented with a straightforward and customizable ordering process .
  • Limited Availability: Purple Carrot meal kits may not be available in all areas, limiting accessibility for some customers.
  • With its focus on plant-based cuisine, Purple Carrot offers a unique and enticing alternative to traditional meal delivery services.

Strive Health and Medical Mutual Partner to Bring Value-Based Kidney Care to Ohioans

Retrieved on: 
Tuesday, February 20, 2024

Denver-based Strive Health , the national leader in value-based kidney care, and Medical Mutual , one of the largest Ohio-based health insurance companies, have partnered to deliver value-based kidney care — which focuses on improving quality of care, provider performance and the patient experience — to eligible members with chronic kidney disease (CKD) and end-stage kidney disease.

Key Points: 
  • Denver-based Strive Health , the national leader in value-based kidney care, and Medical Mutual , one of the largest Ohio-based health insurance companies, have partnered to deliver value-based kidney care — which focuses on improving quality of care, provider performance and the patient experience — to eligible members with chronic kidney disease (CKD) and end-stage kidney disease.
  • View the full release here: https://www.businesswire.com/news/home/20240220840878/en/
    Through this partnership, Strive Health will bring value-based kidney care to Medical Mutual members in Ohio.
  • “Providing Medical Mutual members better access to value-based kidney care is an important step in achieving our mission to revolutionize kidney care through comprehensive, patient-centered solutions that improve the quality of life for those affected by CKD,” said Chris Riopelle, Co-Founder and CEO at Strive Health.
  • “We’ve seen great results with patients in slowing the progression of their kidney disease through our care model,” said Farhad Modarai, D.O., Chief Clinical Officer of Population Health at Strive Health.

FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight

Retrieved on: 
Friday, March 8, 2024

"This patient population has a higher risk of cardiovascular death, heart attack and stroke.

Key Points: 
  • "This patient population has a higher risk of cardiovascular death, heart attack and stroke.
  • Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health."
  • Obesity or overweight affect approximately 70% of American adults.
  • Obesity and overweight are serious health issues that increase the risk for premature death and a variety of health problems, including heart attack and stroke.

MemorialCare Medical Group and Greater Newport Physicians Nationally Recognized for Blood Pressure and Diabetes Management by American Heart Association

Retrieved on: 
Friday, March 8, 2024

These awards celebrate a commitment to controlling the blood sugar levels in patients with diabetes and accurate blood pressure measurements.

Key Points: 
  • These awards celebrate a commitment to controlling the blood sugar levels in patients with diabetes and accurate blood pressure measurements.
  • "We are honored to have been nationally recognized by the American Heart Association and American Medical Association," says Dr. David Kim, chief executive officer, MemorialCare Medical Foundation.
  • MemorialCare Medical Group and Greater Newport Physicians earned these awards by achieving an exceptional 70% or greater rate of adhering to cardiovascular-focused clinical measures and controlling high blood pressure throughout its adult patient population.
  • "The high level of care they provide daily shows MemorialCare Medical Group and Greater Newport Physician's commitment to providing quality care for our patients."

Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance

Retrieved on: 
Wednesday, March 6, 2024

The Epitomee® capsule offers an innovative, orally administered, drug free, and clinically proven as effective and safe solution, for adults, who are looking to lose weight.

Key Points: 
  • The Epitomee® capsule offers an innovative, orally administered, drug free, and clinically proven as effective and safe solution, for adults, who are looking to lose weight.
  • Notably, the Epitomee® capsule has already received approval in the European Union and bears a CE mark.
  • "It is an effective and safe treatment for overweight & obesity, promoting weight loss and improvement in Quality of Life.
  • "We are excited to announce the filing of our Weight Loss Capsule data for FDA," said Dr. Dan Hashimshony, CEO of Epitomee Medical.

Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance

Retrieved on: 
Wednesday, March 6, 2024

The Epitomee® capsule offers an innovative, orally administered, drug free, and clinically proven as effective and safe solution, for adults, who are looking to lose weight.

Key Points: 
  • The Epitomee® capsule offers an innovative, orally administered, drug free, and clinically proven as effective and safe solution, for adults, who are looking to lose weight.
  • Notably, the Epitomee® capsule has already received approval in the European Union and bears a CE mark.
  • "It is an effective and safe treatment for overweight & obesity, promoting weight loss and improvement in Quality of Life.
  • "We are excited to announce the filing of our Weight Loss Capsule data for FDA," said Dr. Dan Hashimshony, CEO of Epitomee Medical.